<?xml version="1.0" encoding="UTF-8"?>
<p id="Par13">During the crisis, breast cancer surgery for early lesions and suspected benign pathology should be postponed, and those who have finished neoadjuvant therapy can wait for an additional 2–3 weeks on case-to-case basis. Those with progressive disease on systemic therapy, angiosarcoma and malignant phyllode tumours should be offered surgery on a priority basis. Most surgeries for endocrine tumours can be postponed, unless those with impending airway threat, pheochromocytoma and functional neuroendocrine tumours refractory to medical management. Gynaecological malignancies can be aggressive if delayed, hence most guidelines recommended to go ahead with surgery wherever feasible. Infections including joints and impending pathological fractures including peri-prosthetic fractures, soft tissue extremity sarcomas in the radiation or chemotherapy window and aggressive benign tumours like giant cell tumours should be offered surgical interventions as and when required [
 <xref ref-type="bibr" rid="CR28">28</xref>–
 <xref ref-type="bibr" rid="CR30">30</xref>, 
 <xref ref-type="bibr" rid="CR45">45</xref>].
</p>
